Unknown

Dataset Information

0

Effect of Gender on Clinical Outcomes in Patients Receiving CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

ABSTRACT:

SUBMITTER: Gustafson C 

PROVIDER: S-EPMC7578089 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Effect of Gender on Clinical Outcomes in Patients Receiving <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

Gustafson Chelsea C   Gower Megan N MN   Williams Alexis K AK   Pauley Eric E   Weck Karen E KE   Lee Craig R CR   Stouffer George A GA  

Circulation. Genomic and precision medicine 20200916 5

Similar Datasets

Unknown Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
| S-EPMC7902344 | biostudies-literature
Unknown Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
| S-EPMC5775044 | biostudies-literature
Unknown Clinical Outcomes and Sustainability of Using <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
| S-EPMC5889089 | biostudies-literature
Unknown <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings.
| S-EPMC9245803 | biostudies-literature
Unknown Effects of aging on clinical outcomes in patients receiving genotype-guided P2Y12 inhibitor selection after percutaneous coronary intervention.
| S-EPMC8688255 | biostudies-literature
Unknown Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y<sub>12</sub> Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China.
| S-EPMC7854467 | biostudies-literature
Unknown Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data.
| S-EPMC7417282 | biostudies-literature
Unknown Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention.
| S-EPMC7772580 | biostudies-literature
Unknown Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention.
| S-EPMC5896099 | biostudies-literature
Unknown A case for genotype-guided de-escalation of antiplatelet therapy after percutaneous coronary angioplasty.
| S-EPMC7270838 | biostudies-literature